Biofrontera (BFRI) Inventory Average (2021 - 2025)

Biofrontera's Inventory Average history runs 5 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• On a quarterly basis, Inventory Average fell 56.31% year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $2.9 million, a 56.31% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 54.02% from the prior year.
• Inventory Average retreated to $2.9 million in Q4 2025 per BFRI's latest filing, from $4.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $13.5 million in Q4 2023 and bottomed at $2.9 million in Q4 2025.
• The 5-year median for Inventory Average is $6.6 million (2024), against an average of $6.8 million.
• Across the five-year window, Inventory Average soared 94.55% in 2022 and slumped 56.31% in 2025, its largest moves.
• Year by year, Inventory Average stood at $4.9 million in 2021, then surged by 94.55% to $9.6 million in 2022, then jumped by 40.1% to $13.5 million in 2023, then plunged by 51.17% to $6.6 million in 2024, then slumped by 56.31% to $2.9 million in 2025.
• Per Business Quant, the three latest BFRI Inventory Average figures stand at $2.9 million (Q4 2025), $4.2 million (Q3 2025), and $5.3 million (Q2 2025).